To evaluate the efficacy of a new multimodal antidepressant, vortioxetine (VO), in the management of burning mouth syndrome (BMS).
Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study / Adamo, Daniela; Pecoraro, Giuseppe; Aria, Massimo; Favia, Gianfranco; Mignogna, Michele Davide. - In: PAIN MEDICINE. - ISSN 1526-2375. - (2020). [10.1093/pm/pnz120]
Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study
Aria, Massimo;Mignogna, Michele Davide
2020
Abstract
To evaluate the efficacy of a new multimodal antidepressant, vortioxetine (VO), in the management of burning mouth syndrome (BMS).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
pnz120.pdf
accesso aperto
Licenza:
Dominio pubblico
Dimensione
259.99 kB
Formato
Adobe PDF
|
259.99 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
